Table 6.
Estimation of the prevalence and incidence of motor neuron disease (MND) and its variants in the regions of Valencia and Catalonia (2013–2018 and 2011–2019).
| Estimation of the prevalence and incidence of mnd and variants, stratified by region | |||
|---|---|---|---|
| Valencia (n = 259) | Catalonia (n = 591) | ||
| Prevalence (per 100,000 inhabitants) | |||
| Variables | |||
| MNDa | 4.216 (2.652–6.334) | 5.627 (3.990–7.662) | |
| Definite diagnosisa | |||
| ALS | 3.249 (1.911–5.120) | 4.721 (3.248–6.608) | |
| PMA | 0.480 (0.065–1.650) | 0.602 (0.008–0.634) | |
| PLS | 0.378 (0.046–1.896) | 0.662 (0.000–1.987) | |
| Incidence (per 100,000 person-years) | |||
| Variables | |||
| MNDa | 1.390 (0.822–2.165) | 2.346 (1.682–3.152) | |
| Definite diagnosisa | |||
| ALS | 1.080 (0.598–1.754) | 1.935 (1.351–2.656) | |
| PMA | 0.222 (0.009–1.027) | 0.415 (0.225–0.628) | |
| PLS | 0.202 (1.306e-09–0.564) | 0.476 (0.409–0.544) | |
MND Moto Neuron Disease, ALS Amyotrophic Lateral Sclerosis, PMA Progressive Muscular Atrophy, PLS Primary Lateral Sclerosis.
aPoint estimate (credibility interval at 95%).